Cabot Co. (NYSE:CBT) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC decreased its stake in shares of Cabot Co. (NYSE:CBT) by 6.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,158 shares of the specialty chemicals company’s stock after selling 2,216 shares during the quarter. Mutual of America Capital Management LLC owned about 0.06% of Cabot worth $2,852,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the stock. Mariner LLC increased its stake in Cabot by 4.1% during the 3rd quarter. Mariner LLC now owns 3,433 shares of the specialty chemicals company’s stock valued at $238,000 after purchasing an additional 136 shares in the last quarter. Metropolitan Life Insurance Co NY increased its stake in Cabot by 4.4% during the 4th quarter. Metropolitan Life Insurance Co NY now owns 3,418 shares of the specialty chemicals company’s stock valued at $228,000 after purchasing an additional 143 shares in the last quarter. Creative Planning increased its stake in Cabot by 2.8% during the 3rd quarter. Creative Planning now owns 5,797 shares of the specialty chemicals company’s stock valued at $402,000 after purchasing an additional 158 shares in the last quarter. Commonwealth Equity Services LLC boosted its holdings in shares of Cabot by 3.4% in the 1st quarter. Commonwealth Equity Services LLC now owns 4,857 shares of the specialty chemicals company’s stock valued at $372,000 after acquiring an additional 159 shares during the last quarter. Finally, Arizona State Retirement System boosted its holdings in shares of Cabot by 1.0% in the 3rd quarter. Arizona State Retirement System now owns 15,986 shares of the specialty chemicals company’s stock valued at $1,107,000 after acquiring an additional 166 shares during the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Stock Performance

Shares of NYSE CBT opened at $90.66 on Friday. The company’s fifty day moving average price is $88.06 and its 200 day moving average price is $79.48. Cabot Co. has a 1 year low of $63.73 and a 1 year high of $98.34. The company has a market capitalization of $5.03 billion, a PE ratio of 11.77, a price-to-earnings-growth ratio of 0.98 and a beta of 1.28. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.30 and a current ratio of 2.04.

Cabot (NYSE:CBT) last announced its quarterly earnings results on Monday, February 5th. The specialty chemicals company reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.07. The firm had revenue of $958.00 million for the quarter, compared to the consensus estimate of $927.28 million. Cabot had a net margin of 11.24% and a return on equity of 25.52%. On average, research analysts predict that Cabot Co. will post 6.58 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of Cabot from a “buy” rating to a “hold” rating and upped their price objective for the company from $88.00 to $95.00 in a report on Thursday. StockNews.com downgraded shares of Cabot from a “strong-buy” rating to a “buy” rating in a report on Wednesday, February 14th. Mizuho assumed coverage on shares of Cabot in a report on Wednesday, March 27th. They issued a “buy” rating and a $104.00 price objective on the stock. Finally, UBS Group downgraded shares of Cabot from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $90.00 to $87.00 in a report on Monday, January 8th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Cabot has a consensus rating of “Moderate Buy” and a consensus target price of $90.17.

Insider Buying and Selling at Cabot

In other Cabot news, EVP Jeff Ji Zhu sold 55,233 shares of the stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $79.91, for a total transaction of $4,413,669.03. Following the transaction, the executive vice president now directly owns 97,201 shares of the company’s stock, valued at $7,767,331.91. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 3.07% of the company’s stock.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.